NCOG Still Alive, But Not Without Fight On NCAB In Test Of Regional Cooperative Group Concept
In Brief: NCI Grants Get More Money, Pay Line Boosted To 193
For R01s, 195 or P01s Center Funds Up By $600,000
DCAB Board Okays One Contract Concept, Sends Another Back to Drawing Board
NCI Continues Making Improvements In Contract Management
Shubik Warns NCA Members They May Be Prober’s Next Target
FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- Proposed OMB rule aims at the heart of the U.S. research enterprise—and scientists are fighting back
“The question isn’t whether politics will influence research. Under this proposal, that’s the point. That’s their goal.”
